Keros Therapeutics, Inc.KROSNASDAQ
LOADING
|||
Operating cash flow minus capital expenditures
| Period | Value | Change |
|---|---|---|
| 2024 | $-162.80M | -28.2% |
| 2023 | $-126.97M | -78.1% |
| 2022 | $-71.30M | -12.9% |
| 2021 | $-63.17M | -69.9% |
| 2020 | $-37.19M | -128.6% |
| 2019 | $-16.27M | -338.4% |
| 2018 | $6.83M | - |